• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 16.28
  • VXN 20.77
  • VXO 17.15
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)

Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

Last Trade Dividend/Share PE Ratio
Date Dividend Yield Return on Assets
Change ExDividend Date Return on Capital
Bid Latest EPS Price/Sale
Ask LatestEPS Date Price to Book
Volume EPS ttm Institutional %
Avg Volume Shares Outstanding Insider %
Open Float Short Ratio
Prev Close Return On Equity 5 Year Change %
High Consensus EPS 2 Year Change %
Low No. of Estimate 1 Year Change %
52 Week High EPS Surprise $ YTD Change %
52 Week Low EPS Surprise Percent 6 Month Change %
52 Week Change EBITDA 3 Month Change %
50 Day MA Revenue 1 Month Change %
200 Day MA Gross Profit 5 Day Change %
Market Cap Cash 30 Day Change %
Beta Debt Stock Exchange
Sector Revenue Per Share Short Interest
Short Date Revenue Per Employee Short Ratio
Data courtesy of IEX
Company Profile

Rockwell Medical Technologies, Inc. manufactures and sells hemodialysis concentrate solutions and dialysis kits to hemodialysis providers, targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally. It manufactures, sells, distributes, and delivers hemodialysis concentrates, as well as a line of ancillary hemodialysis products to hemodialysis providers and distributors located in 37 states and territories, as well as various countries, primarily in Latin America, Asia, and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys, known as end stage renal disease, an advanced stage of chronic kidney disease characterized by the irreversible loss of kidney function. It offers Renal Pure liquid acid concentrates, Dri-Sate dry acid concentrate and mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate, as well as a range of ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Rockwell Medical Technologies sells its products through direct salespeople and independent sales representation companies; and to certain international customers through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.